We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Latin America’s IVD Sector Exceeds USD 2 Billion, Brazil leads

By LabMedica International staff writers
Posted on 29 Mar 2015
The Latin American in vitro diagnostics (IVD) sector was estimated at USD 2.4 billion in 2014. More...
Population growth, government insurance, newly insured patients, and updated healthcare facilities have driven growth in the region and will continue to propel demand, according to Kalorama Information (New York, NY, USA).

Kalorama based its finding on market research and interviews with IVD manufacturers and distributors. The analysis, published in Kalorama’s report “The Market for In Vitro Diagnostic Tests In Latin America," focuses on reagents and instruments in the main countries. Brazil, Chile, Columbia, Peru and Argentina are singled out for a deeper level of analysis. Uruguay, Venezuela, Ecuador, and other nations are also considered.

“The maturation of IVD markets in developed countries has IVD companies casting their nets in developing countries where rising incomes and standards of living are anticipated to spark a new health consciousness population with growing demands for quality medical care,” said Bruce Carlson, Kalorama Information publisher, “Latin America is a key target for IVD manufacturers,” expected to give additional opportunities in the near future, at an average annual growth twice the worldwide rate.

Brazil has the number one IVD market in the Latin America. The sector is growing at good pace in Brazil, Chile, and Colombia. Due to their current political and economic situations other nations might lag behind for some time. Kalorama’s report suggests this region’s IVD market is attractive but has large challenges to overcome, about which the report provides guidance.

“One of the challenges is that each country is a world on its own: different regulations on sales, insured populations, reimbursement policies, and a number of logistic issues.” said Mr. Carlson, “That’s why we attempted to provide as much detail as possible by country.” Tailored strategies are needed for each of the countries, which vary in size, healthcare infrastructure, and affordability. Companies preparing to enter this market need to understand regulations, have dedicated bilingual personnel, and optimize post-sales costs through regional training centers.

“Marketing strategies from mature markets might end up failing in these countries,” said Mr. Carlson, “working with distributors that fully understand the region is key.” The report provides information on distributors that lead sales in each country, as well as market share tables for each featured country and for many product categories.

Related Links:

Kalorama Information
Market for In Vitro Diagnostic Tests In Latin America, report



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.